Pharmaceutical powder characterisation and inhaler testing workshop to include expert presentations

Copley Scientific Freeman Technology and Malvern PanalyticalA new workshop organised by Monash University will include invited presentations from Copley Scientific, the world’s leading provider of inhaler testing equipment, Freeman Technology, global leaders in the field of powder characterisation, and ATA Scientific, distributors of Malvern Panalytical materials characterisation systems. Entitled Pharmaceutical Powder Characterisation and Inhaler Testing Workshop, the event will take place on 25 November 2013 in Boronia, Australia. Attendance is free of charge but places are limited. To find out more or to register please go to https://www.freemantech.co.uk/.

Tim Freeman, Managing Director of Freeman Technology, will begin the workshop with a presentation entitled ‘Understanding and characterising pharmaceutical powder flow’. This will include some detailed discussion of the mechanisms of powder flow, but will focus on how powders can be measured to support pharmaceutical applications. A review of traditional powder testing will set in context how more modern methods can be applied to elucidate inhaler performance, and to optimise key pharmaceutical unit operations such as dispensing, blending and granulation.

Concentrating on orally inhaled products (OIPs), Mark Copley will present ‘In vitro testing of pharmaceutical inhalers’, a review of the regulatory framework for OIPs and the in vitro measurement methods used to meet it. These especially cover delivered dose uniformity and aerodynamic particle size distribution (APSD). A key focus will be the technique of cascade impaction which is used to measure the APSD of all OIPs. Mark Copley will provide expert hints and tips on how best to maintain and operate cascade impactors and will give some insight into their use in advancing OIP technology.

Paul Barrett, regional manager at ATA Scientific, will discuss the application of laser diffraction and automated imaging techniques to understanding the performance of dry powder inhalers (DPIs). His case studies will focus on the use of laser diffraction for analysing the aerosolization and dispersion of DPI formulations.  Paul will also described how use of component-specific particle characterisation techniques - combining image analysis,  Raman spectroscopy and cascade impaction - can enable researchers study how particle shape and formulation composition may affect drug delivery.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2023, March 24). Pharmaceutical powder characterisation and inhaler testing workshop to include expert presentations. News-Medical. Retrieved on June 20, 2024 from https://www.news-medical.net/news/20131121/Pharmaceutical-powder-characterisation-and-inhaler-testing-workshop-to-include-expert-presentations.aspx.

  • MLA

    Malvern Panalytical. "Pharmaceutical powder characterisation and inhaler testing workshop to include expert presentations". News-Medical. 20 June 2024. <https://www.news-medical.net/news/20131121/Pharmaceutical-powder-characterisation-and-inhaler-testing-workshop-to-include-expert-presentations.aspx>.

  • Chicago

    Malvern Panalytical. "Pharmaceutical powder characterisation and inhaler testing workshop to include expert presentations". News-Medical. https://www.news-medical.net/news/20131121/Pharmaceutical-powder-characterisation-and-inhaler-testing-workshop-to-include-expert-presentations.aspx. (accessed June 20, 2024).

  • Harvard

    Malvern Panalytical. 2023. Pharmaceutical powder characterisation and inhaler testing workshop to include expert presentations. News-Medical, viewed 20 June 2024, https://www.news-medical.net/news/20131121/Pharmaceutical-powder-characterisation-and-inhaler-testing-workshop-to-include-expert-presentations.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Insights into exosomes role in disease transmission gained using NanoSight from Malvern